(Total Views: 604)
Posted On: 08/03/2020 10:03:25 AM
Post# of 72446
I agree that Leo having complete pricing flexibility would be a very good thing. As an example, the price could be set at $1000 per dose but give the US a $500 discount on the first 1,000,000 doses in exchange for an Emergency Use Authorization (EUA) and grant funding to pay for any trials required for full FDA approval. Win/win...
You said, “If Brilacidin performs at a similar efficacy in human trials as proven in labs (80% more effective in viral reduction as Remdesivir) and Leo decides to price below Remdesivir it will be a no-brainer for the U.S. government to endorse Brilacidin as the top CV19 treatment.
Read More: https://investorshangout.com/post/viewall?id=...40FwW3B”
You said, “If Brilacidin performs at a similar efficacy in human trials as proven in labs (80% more effective in viral reduction as Remdesivir) and Leo decides to price below Remdesivir it will be a no-brainer for the U.S. government to endorse Brilacidin as the top CV19 treatment.
Read More: https://investorshangout.com/post/viewall?id=...40FwW3B”
(7)
(0)
